« Return to News | Drug Sponsors

J&J looking to acquire Synthes

Tuesday, April 19, 2011 11:21 AM

Johnson & Johnson is looking to acquire global medical device manufacturer Synthes in a deal that could be worth around $20 billion as reported in Pharma Times.

While Synthes indicated the company has been talking about a deal, no further comments have been made.

Synthes develops, manufactures and markets instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues, and currently employs nearly 11,500 people worldwide.

Last year, Synthes’ sales totaled $3.7 billion, making the company an attractive buy for J&J.

According to Vontobel analyst Carla Baenziger, a partnership between the two firms would double J&J's market share in spinal care to 30%, making it second only to MedTronic, and making it first in U.S. market for trauma with a share of around 57%, media reports note.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.